(Q43062153)

English

Molecular profiling of invasive breast cancer by multiplex ligation-dependent probe amplification-based copy number analysis of tumor suppressor and oncogenes

scientific article published on 14 May 2010

In more languages

default for all languages

No label defined

No description defined

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

13 November 2017

Molecular profiling of invasive breast cancer by multiplex ligation-dependent probe amplification-based copy number analysis of tumor suppressor and oncogenes (English)

1 reference

Europe PubMed Central

PubMed publication ID

13 November 2017

Cathy B Moelans

1

1 reference

Europe PubMed Central

PubMed publication ID

13 November 2017

author name string

Roel A de Weger

2

1 reference

Europe PubMed Central

PubMed publication ID

13 November 2017

Hanneke N Monsuur

3

1 reference

Europe PubMed Central

PubMed publication ID

13 November 2017

Raymon Vijzelaar

4

1 reference

Europe PubMed Central

PubMed publication ID

13 November 2017

Paul J van Diest

5

1 reference

Europe PubMed Central

PubMed publication ID

13 November 2017

publication date

14 May 2010

1 reference

Europe PubMed Central

PubMed publication ID

13 November 2017

Modern Pathology

1 reference

Europe PubMed Central

PubMed publication ID

13 November 2017

23

1 reference

Europe PubMed Central

PubMed publication ID

13 November 2017

7

1 reference

Europe PubMed Central

PubMed publication ID

13 November 2017

1029-1039

1 reference

Europe PubMed Central

PubMed publication ID

13 November 2017

Predictive value of topoisomerase IIalpha and other prognostic factors for epirubicin chemotherapy in advanced breast cancer

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2010.84

21 January 2018

Amplification and deletion of topoisomerase IIalpha associate with ErbB-2 amplification and affect sensitivity to topoisomerase II inhibitor doxorubicin in breast cancer

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2010.84

21 January 2018

HER2 amplification ratios by fluorescence in situ hybridization and correlation with immunohistochemistry in a cohort of 6556 breast cancer tissues

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2010.84

7 January 2021

based on heuristic

inferred from DOI database lookup

Targeted therapy in breast cancer: the HER-2/neu gene and protein

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2010.84

7 January 2021

based on heuristic

inferred from DOI database lookup

Studies of the HER-2/neu proto-oncogene in human breast and ovarian cancer

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2010.84

7 January 2021

based on heuristic

inferred from DOI database lookup

Use of chemotherapy plus a monoclonal antibody against HER2 for metastatic breast cancer that overexpresses HER2.

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2010.84

7 January 2021

based on heuristic

inferred from DOI database lookup

Trastuzumab--mechanism of action and use in clinical practice

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2010.84

7 January 2021

based on heuristic

inferred from DOI database lookup

Human breast cancer: correlation of relapse and survival with amplification of the HER-2/neu oncogene

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2010.84

7 January 2021

based on heuristic

inferred from DOI database lookup

Prognostic and predictive value of c-erbB-2 overexpression in primary breast cancer, alone and in combination with other prognostic markers

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2010.84

7 January 2021

based on heuristic

inferred from DOI database lookup

ERBB2 amplification is associated with tamoxifen resistance in steroid-receptor positive breast cancer

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2010.84

7 January 2021

based on heuristic

inferred from DOI database lookup

c-erb B2 overexpression decreases the benefit of adjuvant tamoxifen in early-stage breast cancer without axillary lymph node metastases

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2010.84

7 January 2021

based on heuristic

inferred from DOI database lookup

Topoisomerase IIalpha gene amplification predicts favorable treatment response to tailored and dose-escalated anthracycline-based adjuvant chemotherapy in HER-2/neu-amplified breast cancer: Scandinavian Breast Group Trial 9401

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2010.84

7 January 2021

based on heuristic

inferred from DOI database lookup

Topoisomerase II alpha and responsiveness of breast cancer to adjuvant chemotherapy

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2010.84

7 January 2021

based on heuristic

inferred from DOI database lookup

Simultaneous detection of TOP2A and HER2 gene amplification by multiplex ligation-dependent probe amplification in breast cancer

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2010.84

7 January 2021

based on heuristic

inferred from DOI database lookup

Estrogen receptor alpha (ESR1) gene amplification is frequent in breast cancer.

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2010.84

7 January 2021

based on heuristic

inferred from DOI database lookup

Conflicting evidence on the frequency of ESR1 amplification in breast cancer

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2010.84

7 January 2021

based on heuristic

inferred from DOI database lookup

Chromogenic and fluorescent in situ hybridization in breast cancer

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2010.84

7 January 2021

based on heuristic

inferred from DOI database lookup

CCND1 amplification and cyclin D1 expression in breast cancer and their relation with proteomic subgroups and patient outcome

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2010.84

7 January 2021

based on heuristic

inferred from DOI database lookup

Deciphering a subgroup of breast carcinomas with putative progression of grade during carcinogenesis revealed by comparative genomic hybridisation (CGH) and immunohistochemistry.

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2010.84

7 January 2021

based on heuristic

inferred from DOI database lookup

In lymph node-negative invasive breast carcinomas, specific chromosomal aberrations are strongly associated with high mitotic activity and predict outcome more accurately than grade, tumour diameter, and oestrogen receptor

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2010.84

7 January 2021

based on heuristic

inferred from DOI database lookup

Molecular characterization of breast cancer with high-resolution oligonucleotide comparative genomic hybridization array.

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2010.84

7 January 2021

based on heuristic

inferred from DOI database lookup

Relative quantification of 40 nucleic acid sequences by multiplex ligation-dependent probe amplification

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2010.84

7 January 2021

based on heuristic

inferred from DOI database lookup

Comparison of multiplex ligation dependent probe amplification to immunohistochemistry for assessing HER-2/neu amplification in invasive breast cancer.

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2010.84

7 January 2021

based on heuristic

inferred from DOI database lookup

HER-2/neu amplification testing in breast cancer by Multiplex Ligation-dependent Probe Amplification: influence of manual- and laser microdissection

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2010.84

7 January 2021

based on heuristic

inferred from DOI database lookup

Prognostic value of proliferation in invasive breast cancer: a review

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2010.84

7 January 2021

based on heuristic

inferred from DOI database lookup

No consent should be needed for using leftover body material for scientific purposes. For.

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2010.84

7 January 2021

based on heuristic

inferred from DOI database lookup

Reproducibility of mitosis counting in 2,469 breast cancer specimens: results from the Multicenter Morphometric Mammary Carcinoma Project

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2010.84

7 January 2021

based on heuristic

inferred from DOI database lookup

Dosage analysis of cancer predisposition genes by multiplex ligation-dependent probe amplification

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2010.84

7 January 2021

based on heuristic

inferred from DOI database lookup

Prognostic relevance of gene amplifications and coamplifications in breast cancer

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2010.84

7 January 2021

based on heuristic

inferred from DOI database lookup

Frequency, prognostic impact, and subtype association of 8p12, 8q24, 11q13, 12p13, 17q12, and 20q13 amplifications in breast cancers

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2010.84

7 January 2021

based on heuristic

inferred from DOI database lookup

Correlation of amplification and overexpression of the c-myc oncogene in high-grade breast cancer: FISH, in situ hybridisation and immunohistochemical analyses

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2010.84

7 January 2021

based on heuristic

inferred from DOI database lookup

Genomic and transcriptional aberrations linked to breast cancer pathophysiologies

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2010.84

7 January 2021

based on heuristic

inferred from DOI database lookup

DNA copy number changes detected by comparative genomic hybridization and their association with clinicopathologic parameters in breast tumors

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2010.84

7 January 2021

based on heuristic

inferred from DOI database lookup

Activation of multiple cancer-associated genes at the ERBB2 amplicon in breast cancer

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2010.84

7 January 2021

based on heuristic

inferred from DOI database lookup

Co-amplified genes at 8p12 and 11q13 in breast tumors cooperate with two major pathways in oncogenesis

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2010.84

7 January 2021

based on heuristic

inferred from DOI database lookup

Array comparative genomic hybridization analysis of genomic alterations in breast cancer subtypes

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2010.84

7 January 2021

based on heuristic

inferred from DOI database lookup

Breast tumor copy number aberration phenotypes and genomic instability

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2010.84

7 January 2021

based on heuristic

inferred from DOI database lookup

Gene amplification and overexpression of PRDM14 in breast cancers.

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2010.84

7 January 2021

based on heuristic

inferred from DOI database lookup

Identification and validation of prognostic markers in breast cancer with the complementary use of array-CGH and tissue microarrays

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2010.84

7 January 2021

based on heuristic

inferred from DOI database lookup

Genetic alterations of CCND1 and EMSY in breast cancers

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2010.84

7 January 2021

based on heuristic

inferred from DOI database lookup

EMSY links the BRCA2 pathway to sporadic breast and ovarian cancer

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2010.84

7 January 2021

based on heuristic

inferred from DOI database lookup

EGFR gene and protein expression in breast cancers

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2010.84

7 January 2021

based on heuristic

inferred from DOI database lookup

MYC amplification in breast cancer: a chromogenic in situ hybridisation study

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2010.84

7 January 2021

based on heuristic

inferred from DOI database lookup

E-cadherin and loss of heterozygosity at chromosome 16 in breast carcinogenesis: different genetic pathways in ductal and lobular breast cancer?

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2010.84

7 January 2021

based on heuristic

inferred from DOI database lookup

TRAF4 overexpression is a common characteristic of human carcinomas

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2010.84

7 January 2021

based on heuristic

inferred from DOI database lookup

The LIM and SH3 domain protein family: structural proteins or signal transducers or both?

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2010.84

7 January 2021

based on heuristic

inferred from DOI database lookup

Amplification and overexpression of peroxisome proliferator-activated receptor binding protein (PBP/PPARBP) gene in breast cancer

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2010.84

7 January 2021

based on heuristic

inferred from DOI database lookup

Genomic analysis of the HER2/TOP2A amplicon in breast cancer and breast cancer cell lines

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2010.84

7 January 2021

based on heuristic

inferred from DOI database lookup

Frequent amplifications and deletions of G1/S-phase transition genes, CCND1 and MYC in early breast cancers: a potential role in G1/S escape.

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2010.84

7 January 2021

based on heuristic

inferred from DOI database lookup

Prognosis and gene expression profiling of 20q13-amplified breast cancers

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2010.84

7 January 2021

based on heuristic

inferred from DOI database lookup

A putative serine/threonine kinase encoding gene BTAK on chromosome 20q13 is amplified and overexpressed in human breast cancer cell lines

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2010.84

7 January 2021

based on heuristic

inferred from DOI database lookup

FGFR1 amplification in breast carcinomas: a chromogenic in situ hybridisation analysis

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2010.84

7 January 2021

based on heuristic

inferred from DOI database lookup

Mapping the chromosome 16 cadherin gene cluster to a minimal deleted region in ductal breast cancer

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2010.84

7 January 2021

based on heuristic

inferred from DOI database lookup

retrospective analysis of topoisomerase IIa amplifications and deletions as predictive markers in primary breast cancer patients randomly assigned to cyclophosphamide, methotrexate, and fluorouracil or cyclophosphamide, epirubicin, and fluorouracil:

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2010.84

7 January 2021

based on heuristic

inferred from DOI database lookup

Identifiers

10.1038/MODPATHOL.2010.84

1 reference

Europe PubMed Central

PubMed publication ID

13 November 2017

Dimensions Publication ID

0 references

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

13 November 2017

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q43062153&oldid=2205773923"